EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma

Xiangyu Zhang, Yutong Zhao, Cheng Qin, Zeru Li, Yiping Xie, Yutong Yan, Tianyu Li, Lirui Huang, Haoyu Shi, Weibin Wang

Cellular Oncology · 29.06.2026 · 49 (5)

DOI: 10.1007/s13402-026-01251-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 29.06.2026. Verfasst von Xiangyu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Peking Union Medical College Hospital, Department of General Surgery, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatitis, Acinar Cells, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ollege Student Innovation Training Program of Peking Union Medical College, Beijing, Fundamental Research Funds for the Central Universities, Peking Union Medical College, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinar-ductal metaplasia (ADM) represents a dynamic and reversible cellular adaptation in the pancreas, whereby acinar cells dedifferentiate and transdifferentiate into duct-like cells in response to inflammatory, metabolic, and environmental stressors. While transient ADM facilitates tissue repair after acute injury, persistent stimuli—including chronic pancreatitis, metabolic dysregulation, obesity, diabetes, smoking, and oncogenic KRAS mutations—stabilize ADM and promote progression to pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC). ADM is orchestrated by integrated signaling networks involving TGF-β/SMAD, EGFR–KRAS–MAPK, PI3K–AKT–mTOR, Notch, Wnt/β-catenin, and JAK/STAT3, which regulate dedifferentiation, proliferation, survival, and fibrosis. Inflammatory cells, particularly macrophages and eosinophils, and pro-inflammatory cytokines such as IL‑6, IL‑18, and TNF‑α further amplify ADM and create a tumor-promoting microenvironment. Single-cell analyses reveal that ADM encompasses heterogeneous cell states with distinct lineage trajectories, determining reversibility or pre-neoplastic transformation. Pharmacological interventions, including HDAC inhibitors, JAK/STAT3 inhibitors, metformin, and anti-inflammatory agents, show potential in preventing or reversing ADM. Understanding the complex molecular, cellular, and environmental regulation of ADM provides critical insights into pancreatic regeneration and early tumorigenesis and offers a framework for developing targeted strategies for the prevention and treatment of pancreatitis and PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatitisAcinar CellsPancreatic NeoplasmsPancreatic DuctsHumansMetaplasiaAnimalsSignal Transduction

Stichwörter der Autor:innen

Acinar-ductal metaplasiaPancreatic ductal adenocarcinomaPancreatitisPreneoplastic intraepithelial neoplasia

Autor:innen und Institutionen

  • Peking Union Medical College Hospital, Department of General Surgery, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100023, P.R. China.
  • Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, 100023, P.R. China.
  • National Science and Technology Key Infrastructure on Translational Medicine in Peking Union Medical College Hospital, Beijing, 100023, P.R. China.
  • Peking Union Medical College Hospital, Department of General Surgery, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100023, P.R. China. wwb_xh@163.com.
  • Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, 100023, P.R. China. wwb_xh@163.com.
  • National Science and Technology Key Infrastructure on Translational Medicine in Peking Union Medical College Hospital, Beijing, 100023, P.R. China. wwb_xh@163.com.

Förderung

  • ollege Student Innovation Training Program of Peking Union Medical College, Beijing
  • Fundamental Research Funds for the Central Universities, Peking Union Medical College
  • National High Level Hospital Clinical Research Funding
  • Postdoctoral Fellowship Program of CPSF under Grant
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases
  • Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences

Zitieren

APA

Zhang, X., Zhao, Y., Qin, C., Li, Z., Xie, Y., Yan, Y., Li, T., Huang, L., Shi, H., & Wang, W. (2026). Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma. Cellular Oncology, 49(5). https://doi.org/10.1007/s13402-026-01251-0

Vancouver

Zhang X, Zhao Y, Qin C, Li Z, Xie Y, Yan Y, et al. Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma. Cellular Oncology. 2026;49(5). doi:10.1007/s13402-026-01251-0

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiangyu and Zhao, Yutong and Qin, Cheng and Li, Zeru and Xie, Yiping and Yan, Yutong and Li, Tianyu and Huang, Lirui and Shi, Haoyu and Wang, Weibin},
  title = {Acinar-ductal metaplasia in pancreatitis and pancreatic ductal adenocarcinoma},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {5},
  doi = {10.1007/s13402-026-01251-0}
}
Kostenlos starten →